BSF Enterprise PLC - London-based investment company focused on biotechnology solutions - Provides an update on the progress of City-Mix, its flagship commercial product of its subsidiary 3D Bio Tissues. City-Mix is a non-toxic culture media supplement, acting as a ‘cell booster’. Says a number of commercial opportunities have arisen for 3D Bio Tissues since designing its Go To Market plan for City-Mix. Notably, 3D Bio Tissues secures it first agreement since completing its evaluation of City-Mix. Adds 3D Bio Tissues has engaged with 60 companies, with 26 progressing to new business opportunities. Says ED Bio Tissues is also engaging with distributors in the UK, France, Canada, Australia, Switzerland, Italy and the Netherlands. Consequently, company more than double its lab production space and validates its City-Mix production and quality control processes. Current production capacity is 2,500 litres per share.

Current stock price: 16.00 pence

12-month change: up 78%

Copyright 2023 Alliance News Ltd. All Rights Reserved.